In this article

What is the Case Presentation LX? 

The Autonomous Case Presentation is an Autonomous Learning Experience (LX) that can be used to record and guide self-reflection on an occasion where a pharmacist has verbally presented a case to colleagues. The case included in the oral presentation will be retrospective in nature and can be from a direct patient or indirect patient area of practice. 

An Autonomous Case presentation can be used for inclusion towards ANCAP recognition. 

Similar to a Case Based Discussion (CBD), a case presentation allows the pharmacist to highlight professional knowledge, judgement and problems solving skills through retrospective review of a real case they have been involved in. However, the setting is a more formal presentation to a group of colleagues rather than a one-on-one collaborator interaction.  

The main outcome of the Autonomous Case Presentation is to encourage self-reflection of current professional practice (knowledge, critical thinking, problem solving and presentation skills) in a chosen professional setting or topic. 

Examples

• Management of a person with difficult to control blood glucose levels 

• Identifying and managing a significant adverse drug reaction 

• A patient who has recently had an HMR/RMMR 

• Review of a significant medication error that reached a patient at a multi-disciplinary mortality and morbidity meeting 

• Management of a person with multi-resistant infection 

• Education strategies used in a group of undergraduate students being supervised on a placement 

Case Presentation Process 

Choosing a Case 

A Case Presentation can focus on either a direct patient or indirect patient case. See examples above. 

Ideally a CP should focus on a case that is retrospective i.e., a case where the pharmacist has previously been involved in the delivery or care. Ultimately the case, complexity and presentation style will vary depending on the professional setting that the pharmacist has access to present at and the practice recognition level they are aiming to meet. 

Practice Recognition Level 

The Case Presentation Learning Experience is mapped to:

• Domain 1 & 2 of the National Competency Standards Framework for Pharmacists in Australia 2016. Please note that not all the domain 1 & 2 indicators listed in this document may be relevant to this Learning Experience.

• Domain 1, 2, 3, 5 and 7 of the Competence Standards for Pharmacists in Aotearoa New Zealand Pharmacists, 2023. Please note that not all the Domain 1, 2, 3, 5 and 7 behaviours listed in these competence standards may be relevant to this Learning Experience.

The pharmacist must identify a case presentation opportunity that applies to their current level of practice (e.g. ANZCAP resident, register or consultant) and area of specialty.

Please refer to the ANZCAP recognition descriptors article for the further guidance on markers of performance for each ANZCAP recognition level.

Complexity 

In some scenarios the same case may be used for pharmacists aiming for different levels of practice recognition. However, the complexity and expected knowledge & skills will vary. 

Collaborator 

Pharmacists may have engaged in discussion with professional peers, mentors or managers to encourage reflective practice. However, this is an Autonomous Learning Experience and therefore the final submission should be completed by the pharmacist without collaboration. 

Reflection & Goal Setting 

 The pharmacist is encouraged to utilize the SMART goal technique to develop any learning or development goals that are identified from self-reflection after the experience. 

Forms and Templates 

Evidence of the CP is documented directly into the ANZCAP digital platform as an Autonomous Learning Experience (LX). For further step by step instructions on how to do this please refer to the How to complete a Learning Experience article.

If ANZCAP members wish to use a CP form from their own organisation, the completed form may be uploaded into the Supporting Evidence section of the LX. (Please note that for the LX to become validated the candidate must still complete all sections marked with an asterisk ( *) and the collaborator must document their involvement via the electronic collaborator declaration process).

Related articles